T. Rowe Price Associates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.9M | Sell |
114,502
-75,229
| -40% | -$21.6M | ﹤0.01% | 842 |
|
|
2025
Q1 | $58.5M | Sell |
189,731
-208,151
| -52% | -$64.2M | 0.01% | 678 |
|
|
2024
Q4 | $140M | Buy |
397,882
+53,355
| +15% | +$18.8M | 0.02% | 499 |
|
|
2024
Q3 | $123M | Buy |
344,527
+109,611
| +47% | +$39.3M | 0.01% | 526 |
|
|
2024
Q2 | $74.8M | Buy |
234,916
+207,940
| +771% | +$66.2M | 0.01% | 607 |
|
|
2024
Q1 | $6.2M | Sell |
26,976
-5,069
| -16% | -$1.16M | ﹤0.01% | 1179 |
|
|
2023
Q4 | $7.05M | Buy |
32,045
+7,704
| +32% | +$1.69M | ﹤0.01% | 1154 |
|
|
2023
Q3 | $5.5M | Sell |
24,341
-194
| -0.8% | -$43.8K | ﹤0.01% | 1157 |
|
|
2023
Q2 | $5.42M | Buy |
24,535
+431
| +2% | +$95.2K | ﹤0.01% | 1174 |
|
|
2023
Q1 | $5.4M | Buy |
24,104
+596
| +3% | +$133K | ﹤0.01% | 1167 |
|
|
2022
Q4 | $6.54M | Buy |
23,508
+672
| +3% | +$187K | ﹤0.01% | 1130 |
|
|
2022
Q3 | $4.78M | Sell |
22,836
-109,938
| -83% | -$23M | ﹤0.01% | 1212 |
|
|
2022
Q2 | $31.3M | Buy |
132,774
+73,913
| +126% | +$17.4M | ﹤0.01% | 1033 |
|
|
2022
Q1 | $10.6M | Buy |
58,861
+143
| +0.2% | +$25.7K | ﹤0.01% | 1355 |
|
|
2021
Q4 | $12.7M | Sell |
58,718
-1,516
| -3% | -$328K | ﹤0.01% | 1373 |
|
|
2021
Q3 | $11.1M | Sell |
60,234
-1,021
| -2% | -$188K | ﹤0.01% | 1407 |
|
|
2021
Q2 | $11M | Sell |
61,255
-292,869
| -83% | -$52.5M | ﹤0.01% | 1402 |
|
|
2021
Q1 | $59.2M | Buy |
354,124
+110,623
| +45% | +$18.5M | 0.01% | 942 |
|
|
2020
Q4 | $37M | Buy |
243,501
+210,999
| +649% | +$32M | ﹤0.01% | 1052 |
|
|
2020
Q3 | $3.28M | Sell |
32,502
-975
| -3% | -$98.5K | ﹤0.01% | 1458 |
|
|
2020
Q2 | $4.05M | Sell |
33,477
-221,354
| -87% | -$26.8M | ﹤0.01% | 1407 |
|
|
2020
Q1 | $24.2M | Buy |
254,831
+208,234
| +447% | +$19.7M | ﹤0.01% | 1005 |
|
|
2019
Q4 | $4.1M | Buy |
46,597
+5,096
| +12% | +$449K | ﹤0.01% | 1433 |
|
|
2019
Q3 | $3.31M | Buy |
41,501
+248
| +0.6% | +$19.8K | ﹤0.01% | 1445 |
|
|
2019
Q2 | $3.22M | Buy |
41,253
+19
| +0% | +$1.48K | ﹤0.01% | 1462 |
|
|
2019
Q1 | $4.84M | Buy |
41,234
+393
| +1% | +$46.1K | ﹤0.01% | 1405 |
|
|
2018
Q4 | $4.45M | Buy |
40,841
+125
| +0.3% | +$13.6K | ﹤0.01% | 1413 |
|
|
2018
Q3 | $5.21M | Sell |
40,716
-2,704
| -6% | -$346K | ﹤0.01% | 1449 |
|
|
2018
Q2 | $4.91M | Sell |
43,420
-88,361
| -67% | -$10M | ﹤0.01% | 1437 |
|
|
2018
Q1 | $14.8M | Sell |
131,781
-1,069
| -0.8% | -$120K | ﹤0.01% | 1265 |
|
|
2017
Q4 | $19.7M | Sell |
132,850
-48,305
| -27% | -$7.15M | ﹤0.01% | 1186 |
|
|
2017
Q3 | $21.2M | Buy |
181,155
+3,710
| +2% | +$435K | ﹤0.01% | 1150 |
|
|
2017
Q2 | $23M | Buy |
177,445
+6,100
| +4% | +$791K | ﹤0.01% | 1119 |
|
|
2017
Q1 | $23.2M | Sell |
171,345
-3,837
| -2% | -$519K | ﹤0.01% | 1095 |
|
|
2016
Q4 | $25.1M | Sell |
175,182
-6,878
| -4% | -$986K | 0.01% | 1061 |
|
|
2016
Q3 | $21.5M | Buy |
182,060
+15,254
| +9% | +$1.8M | ﹤0.01% | 1100 |
|
|
2016
Q2 | $17.7M | Sell |
166,806
-4,607
| -3% | -$488K | ﹤0.01% | 1138 |
|
|
2016
Q1 | $19.1M | Buy |
171,413
+580
| +0.3% | +$64.6K | ﹤0.01% | 1091 |
|
|
2015
Q4 | $26.8M | Sell |
170,833
-582,731
| -77% | -$91.3M | 0.01% | 993 |
|
|
2015
Q3 | $98.9M | Sell |
753,564
-148,448
| -16% | -$19.5M | 0.02% | 577 |
|
|
2015
Q2 | $157M | Sell |
902,012
-32,254
| -3% | -$5.61M | 0.03% | 494 |
|
|
2015
Q1 | $161M | Sell |
934,266
-22,629
| -2% | -$3.9M | 0.03% | 487 |
|
|
2014
Q4 | $124M | Buy |
956,895
+100,389
| +12% | +$13M | 0.03% | 555 |
|
|
2014
Q3 | $110M | Buy |
856,506
+42,654
| +5% | +$5.49M | 0.02% | 579 |
|
|
2014
Q2 | $72M | Buy |
813,852
+8,295
| +1% | +$734K | 0.02% | 736 |
|
|
2014
Q1 | $75.7M | Buy |
805,557
+317,037
| +65% | +$29.8M | 0.02% | 717 |
|
|
2013
Q4 | $55.2M | Buy |
488,520
+179,600
| +58% | +$20.3M | 0.01% | 804 |
|
|
2013
Q3 | $24.4M | Buy |
308,920
+4,300
| +1% | +$339K | 0.01% | 1027 |
|
|
2013
Q2 | $20.1M | Buy |
+304,620
| New | +$20.1M | 0.01% | 1065 |
|